Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 267 results for "dcgi"

DCGI to approve clinical trial proposals for new drugs approve...

The clinical trial proposals of new drugs already approved in other countries, fixed dose combinations (FDCs), subsequent new drugs, vaccines, etc will henceforth be disposed of by the Drugs Controller General of India (DCGI). This practically ... PharmaBiz, 1 day ago
India issues new requirements for clinical trial approval British Medical Journal, 1 month ago

1 images for "dcgi"

Down to Earth, 1 month ago

DCGI asks state DCs to provide data on Oxytocin to curb its illegal movement in India

The Drugs Controller General of India (DCGI) Dr. GN Singh has directed all the state drug controllers in the country to provide details of the manufacturers of bulk and formulations of oxytocin in their states along with the statistical information ...
 PharmaBiz2 days ago Maha FDA recommends NPPA to bring five categories of medical devices under DPCO  PharmaBiz3 weeks ago DCGI concludes drive to check quality of medicines in Chhatisgarh  PharmaBiz3 weeks ago

DCGI to provide WC certificate to exporters on submission of 6-month stability data

The Central Drugs Standard Control Organisation (CDSCO) will soon start issuing the mandatory Written Confirmation (WC) certificate to the Indian API exporters to European Union (EU) on providing the 6 months long term stability data against the ...
 PharmaBiz3 days ago Dr S Manivannan, Dy DCGI, takes addl charge of sub-zone CDSCO Bengaluru  PharmaBiz1 month ago CDSCO forms 5-member panel headed by Dr. Jagashetty to review manpower structure of CDL, Kolkata  PharmaBiz22 hours ago Indian government takes action over dubious fixed-dose combinations  Pharma Letter1 month ago

Commerce Ministry to meet DCGI, Pharmexcil to discuss exporters issue soon

Commerce Ministry is soon expected to call upon a meeting with the Drug Controller General of India (DCGI) and the Pharmaceuticals Export Promotion Council of India (Pharmexcil) in Delhi, to deliberate over the issues raised by exporters during CPhI ...
 PharmaBiz2 weeks ago Pharmexcil to step up interaction between DCGI, DGFT and stakeholders to help exports  PharmaBiz1 month ago Sensex inches towards 27000; HDFC twins, pharma lead  Money Control1 month ago TROUBLE WORSENING FOR EXPORTERS  PharmaBiz1 month ago

DCGI approves EPIRUS' Remicade biosimilar to market in India

The Drug Controller General of India (DCGI) has approved marketing and manufacturing of Remicade (infliximab) biosimilar BOW015 of EPIRUS Biopharmaceuticals, Inc., a Boston-based biopharmaceutical company focused on the global development and ...
 PharmaBiz1 month ago Epirus gets DCGI nod for arthritis drug biosimilar  Business Standard1 month ago Epirus Remicade Biosimilar Approved in India  FDA News1 month ago EPIRUS BIOPHARMACEUTICALS : ' Remicade® Biosimilar Receives Final Approvals in India  4 Traders1 month ago

Nichi-In to halt Dendriatic cell cancer vaccine

Singapore: India's Chennai-based Nichi-In Center for Regenerative Medicine has been by the DCGI, to stop selling the Dendriatic cell cancer vaccine for Dendriatic immunization therapy. The controller has also issued a safety alert against the use of ...
 Bio Spectrum Asia1 month ago DCGI orders Nichi-In to stop sale of Dendriatic cell cancer vaccine in name of Dendriatic cell immunotherapy  PharmaBiz1 month ago

PMC seeks ban on rapid dengue test kits

PUNE: The health department of the Pune Municipal Corporation (PMC) has urged the Food and Drugs Administration (FDA) to ban the sale of rapid diagnostic test kits for dengue, which are primarily used by private hospitals and pathology laboratories ...
 Times of India2 days ago
Mumbai Mirror

IIT-B wins two national science awards for diabetes testing kits

The Biosciences and Bioengineering departments at IIT Bombay have created two innovative portable diagnostic systems to measure blood sugar and other components. Rohit Srivastava, an associate professor, who has worked on both the projects was ...
 Mumbai Mirror2 days ago

Epistem : Announces Preliminary Results To 30 June 2014

The 2013/14 financial year saw Epistem commence and successfully complete its Indian clinical evaluation study in advance of the planned launch of Genedrive®, its revolutionary handheld molecular diagnostic device, whilst accelerating investment in ...
 4 Traders2 days ago EpiStem : Successful Completion of Genedrive(R) Indian Clinical Trials and Regulatory Submission  4 Traders3 days ago Successful Completion of Genedrive(R) Indian Clinical Trials and Regulatory Submission  Pharmacy Choice3 days ago

Epistem operating losses rise

Epistem Holdings posts operating losses of £2.3m for the year to the end of June - up from £1.5m last time. Revenue and other income - development grant funding - increased to £5.8m from £5.4m. Separately,the group announced the successful ...
 TrustNet3 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less